pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['kn 671', 'nsclc', 'cisplatin', 'pembro', 'sclc']
much excitement for neo/adjuvant pembro in kn 671 nsclc trial .
ironically, the cisplatin shortage means that a foundational piece of the regimen may not be reliably available in the us. 
Breast cancer specialist and professor @DanaFarber Cancer Institute and @HarvardMed. Tweets are my own and not medical advice. COI disclosure: no COI.